Public Act 097-0456
 
SB0670 EnrolledLRB097 04433 RPM 44472 b



    AN ACT concerning regulation.

 
    Be it enacted by the People of the State of Illinois, 
represented in the General Assembly: 

 
    Section 5. The Pharmacy Practice Act is amended  by changing 
Section 26 as follows:
 
    (225 ILCS 85/26)
    (Section scheduled to be repealed on January 1, 2018)
    Sec. 26. Anti-epileptic drug product selection prohibited.
    (a) The General Assembly finds that this Section is 
necessary for the immediate preservation of the public peace, 
health, and safety.
    (b) In this Section:
    "Anti-epileptic drug" means (i) any drug prescribed for the 
treatment of epilepsy or (ii) a drug used to treat or prevent 
seizures.
    "Epilepsy" means a neurological condition characterized by 
recurrent seizures.
    "Seizure" means a brief disturbance in the electrical 
activity of the brain.
    (c) When the prescribing physician has indicated on the 
original prescription "may not substitute", a pharmacist may 
not interchange an anti-epileptic drug or formulation of an 
anti-epileptic drug for the treatment of epilepsy without 
notification and the documented consent of the prescribing 
physician and the patient or the patient's parent, legal 
guardian, or spouse.
This Section does not apply to medication 
orders issued for anti-epileptic drugs for any in-patient care 
in a licensed hospital.

    (d) If a pharmacist substitutes any generic prescription in 
place of a brand-name anti-epileptic drug, then the pharmacist 
shall provide written notice to the patient no later than the 
time the prescription is dispensed. 
(Source: P.A. 94-936, eff. 6-26-06; 95-689, eff. 10-29-07.)